06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.03
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.59x
- Price / sales
- 48.94x
- Price / cash flow
- -2.68x
Enterprise value
- Enterprise value
- HKD 555.4M
- EV / sales
- 64.02x
- EV / EBITDA
- -3.06x
- EV / EBIT
- -2.37x
- Market cap
- HKD 424.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025